Evidence map›Paper›PMID 32309783›Full record

ArticleHemaSphere2020

Clinical Significance of

Barbara Depreter, Barbara De Moerloose, Karl Vandepoele, Anne Uyttebroeck, An Van Damme, Barbara Denys, Laurence Dedeken, Marie-Françoise Dresse, Jutte Van der Werff Ten Bosch, Mattias Hofmans and 4 more

Open access · goldAbstract readLetter
In one paragraph

Article in HemaSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Shared neoantigens for cancer immunotherapy.Molecular therapy. Oncology · 2025
    Review
  3. Article
  4. TARP as antigen in cancer immunotherapy.Cancer immunology, immunotherapy : CII · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Barbara DepreterDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Barbara De MoerlooseDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Karl VandepoeleCancer Research Institute Ghent, Ghent, Belgium.
Anne UyttebroeckDepartment of Pediatrics, University Hospital Gasthuisberg, Leuven, Belgium.
An Van DammeDepartment of Pediatric Hematology Oncology, University Hospital Saint-Luc, Brussels, Belgium.
Barbara DenysDepartment of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Laurence DedekenDepartment of Pediatric Hematology Oncology, Queen Fabiola Children's University Hospital, Brussels, Belgium.
Marie-Françoise DresseDepartment of Pediatric Hematology Oncology, University Hospital Liège, Liège, Belgium.
Jutte Van der Werff Ten BoschDepartment of Pediatric Hematology Oncology, University Hospital Brussel, Brussels, Belgium.
Mattias HofmansDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Tessa KerreCancer Research Institute Ghent, Ghent, Belgium.
Bart VandekerckhoveCancer Research Institute Ghent, Ghent, Belgium.
Jan PhilippéCancer Research Institute Ghent, Ghent, Belgium.
Tim LammensDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Cancer Research Institute Ghent · BEGhent University Hospital · BECliniques Universitaires Saint-Luc · BEErasmus Hospital · BEQueen Fabiola Children's University Hospital · BEUniversitair Ziekenhuis Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32309783
PMCPMC7162082
OpenAlexW3008044284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.